CDK14 Polyclonal Antibody

CDK14 Polyclonal Antibody

The CDK14 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of cyclin-dependent kinase 14 (CDK14) protein expression. This antibody is produced using a polyclonal approach, ensuring a diverse range of epitope recognition and enhanced sensitivity for accurate results.

CDK14, also known as PFTK1 or PFTAIRE1, is a member of the cyclin-dependent kinase family and plays a crucial role in cell cycle regulation and progression. It is involved in various cellular processes, including cell proliferation, differentiation, and apoptosis. Dysregulation of CDK14 has been implicated in several diseases, making it an important target for research and therapeutic development.

The CDK14 Polyclonal Antibody exhibits exceptional specificity, enabling precise detection of CDK14 protein expression in various sample types, including cell lysates and tissue extracts. It has been extensively validated for use in immunoblotting, immunohistochemistry, and immunofluorescence applications.

This antibody is manufactured using high-quality materials and rigorous quality control measures to ensure consistent performance and reproducibility. It is supplied as a liquid formulation, ready for immediate use, and is compatible with a wide range of experimental protocols.

With its superior sensitivity and specificity, the CDK14 Polyclonal Antibody is an indispensable tool for researchers and scientists studying cell cycle regulation, cancer biology, and drug discovery. Its reliable performance and versatility make it an ideal choice for a wide range of applications in both academic and industrial settings.